Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational 20-year, Cross-sectional, Long-term Follow up of the Patient Cohort Enrolled in the Pivotal Study of Betaseron® (Interferon Beta-1b) in Relapsing-remitting Multiple Sclerosis

NCT01031459 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01031459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01031459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational 20-year, Cross-sectional, Long-term Follow up of the Patient Cohort Enrolled in the Pivotal Study of Betaseron® (Interferon Beta-1b) in Relapsing-remitting Multiple Sclerosis
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
December 31, 2010
Enrollment
176 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis